Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Methylprednisolone × Clear all

NCT02962284 2021-11-19

One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™

Phase 2 Completed

20 enrolled 12 charts

Prostatic Neoplasms

NCT00541281 2009-10-27

Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer

Phase 2 Completed

Neoplasm Metastasis, Prostatic Neoplasms